Skip to main content

Table 2 Full schedule of questionnaires – table showing the questionnaires scheduled for the MIR study

From: Mirtazapine added to selective serotonin reuptake inhibitors for treatment-resistant depression in primary care (MIR trial): study protocol for a randomised controlled trial

Questionnaire

Postal screening

Baseline

2 weeks call

6 weeks

12 weeks

24 weeks

12 months

Consent form

 

Y

     

BDI-II

Y

Y

 

Y

Y

Y

Y

Biographic and demographic data including psychiatric history, life events, social support, alcohol use

Y

Y

     

Views on treatment

 

Y

     

Assessment of blinding

    

Y

  

Medication

Y

Y

 

Y

Y

Y

Y

Morisky (adapted)

Y

Y

 

Y

Y

Y

Y

CIS-R

 

Y

     

PHQ9

 

Y

  

Y

Y

Y

GAD-7

 

Y

  

Y

Y

Y

EQ-5D-5L

 

Y

  

Y

Y

Y

SF-12

 

Y

  

Y

Y

Y

Economics

    

Y

Y

Y

Health events (SAEs)

   

Y

Y

Y

Y

ASEC

 

Y

  

Y

 

Y

2-week check

  

Y

    

Blinding questions

    

Y

  

Exit questionnaire

      

Y

  1. ASEC Antidepressant Side Effect Checklist, BDI-II Beck Depression Inventory II, CIS-R Clinical Interview Schedule-Revised version, EQ-5D-5L EuroQol 5 dimensions 5 levels quality of life questionnaire, GAD-7 Generalised Anxiety Disorder-7 questionnaire, PHQ9 Patient Health Questionnaire, SAE Serious Adverse Event, SF-12 social and physical functioning questionnaire short form 12
Back to article page

Trials

ISSN: 1745-6215